Validation process and compliance support in regulated industries

The life sciences industry is experiencing increasing pressures across multiple fronts. Companies must shorten time to market in increasingly global and outsourced environments. At the same time, they must lower operating cost and increase product quality in tighter regulatory environments. This white paper discusses how enterprise asset management (EAM) plays a key role in shortening time to market, lowering operating costs and improving product quality in tighter regulatory environments.